Fundraising Fox
Asieris Pharmaceuticals
Founded 2010 · 60 employees on LinkedIn · 4 known investors
Find your way into Asieris Pharmaceuticals
Sign up to see every warm intro you have to Asieris Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asieris Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.
Founders & leadership
Investors · 4
How we know: EFung Capital's portfolio page · Not right? Tell us
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Asieris Pharmaceuticals do?
- Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.
- Who are Asieris Pharmaceuticals's investors?
- Asieris Pharmaceuticals's investors include EFung Capital, Qiming Venture Partners, TriWise Capital, YF Capital.